Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$331.57
+0.2%
$346.62
$267.83
$391.29
$178.50B0.442.73 million shs4.07 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$421.06
+0.9%
$398.83
$356.28
$555.45
$3.10T1.134.84 million shs27.78 million shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
+0.25%-1.45%-5.31%-11.70%+20.57%
Microsoft Corporation stock logo
MSFT
Microsoft
+0.87%+3.91%+0.72%+5.67%-8.10%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$331.57
+0.2%
$346.62
$267.83
$391.29
$178.50B0.442.73 million shs4.07 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$421.06
+0.9%
$398.83
$356.28
$555.45
$3.10T1.134.84 million shs27.78 million shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
+0.25%-1.45%-5.31%-11.70%+20.57%
Microsoft Corporation stock logo
MSFT
Microsoft
+0.87%+3.91%+0.72%+5.67%-8.10%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amgen Inc. stock logo
AMGN
Amgen
2.48
Hold$355.197.12% Upside
Microsoft Corporation stock logo
MSFT
Microsoft
2.85
Moderate Buy$560.8833.21% Upside

Current Analyst Ratings Breakdown

Latest AMGN and MSFT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2026
Amgen Inc. stock logo
AMGN
Amgen
Lower Price TargetBuy$400.00 ➝ $375.00
5/14/2026
Amgen Inc. stock logo
AMGN
Amgen
Lower Price TargetOverweight$432.00 ➝ $427.00
5/13/2026
Amgen Inc. stock logo
AMGN
Amgen
Lower Price TargetOutperform$410.00 ➝ $390.00
5/13/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Reiterated RatingOutperform$575.00
5/13/2026
Microsoft Corporation stock logo
MSFT
Microsoft
UpgradeBuy$485.00
5/7/2026
Amgen Inc. stock logo
AMGN
Amgen
UpgradeHoldStrong-Buy
5/7/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Lower Price Target$678.00 ➝ $573.00
5/7/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Reiterated RatingBuy
5/6/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Boost Price TargetBuy$595.00 ➝ $680.00
5/5/2026
Microsoft Corporation stock logo
MSFT
Microsoft
DowngradeMarket Perform
5/5/2026
Microsoft Corporation stock logo
MSFT
Microsoft
UpgradeBuyHold
(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amgen Inc. stock logo
AMGN
Amgen
$36.75B4.87$33.90 per share9.78$17.03 per share19.47
Microsoft Corporation stock logo
MSFT
Microsoft
$281.72B11.10$18.45 per share22.82$55.78 per share7.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amgen Inc. stock logo
AMGN
Amgen
$7.71B$14.3723.0714.073.3220.96%137.41%13.28%8/4/2026 (Estimated)
Microsoft Corporation stock logo
MSFT
Microsoft
$101.83B$16.8025.0621.831.5039.34%31.94%18.47%7/29/2026 (Estimated)

Latest AMGN and MSFT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2026Q1 2026
Amgen Inc. stock logo
AMGN
Amgen
$4.77$5.15+$0.38$3.34$8.58 billion$8.62 billion
4/29/2026Q3 2026
Microsoft Corporation stock logo
MSFT
Microsoft
$4.06$4.27+$0.21$4.27$81.44 billion$82.89 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Amgen Inc. stock logo
AMGN
Amgen
$10.083.04%+8.27%70.15%14 Years
Microsoft Corporation stock logo
MSFT
Microsoft
$3.640.86%+10.24%21.67%23 Years

Latest AMGN and MSFT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/10/2026
Microsoft Corporation stock logo
MSFT
Microsoft
quarterly$0.910.86%5/21/20265/21/20266/11/2026
3/4/2026
Amgen Inc. stock logo
AMGN
Amgen
quarterly$2.523.09%5/15/20265/15/20266/5/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amgen Inc. stock logo
AMGN
Amgen
5.65
1.26
1.01
Microsoft Corporation stock logo
MSFT
Microsoft
0.08
1.28
1.27

Institutional Ownership

CompanyInstitutional Ownership
Amgen Inc. stock logo
AMGN
Amgen
76.50%
Microsoft Corporation stock logo
MSFT
Microsoft
71.13%

Insider Ownership

CompanyInsider Ownership
Amgen Inc. stock logo
AMGN
Amgen
0.85%
Microsoft Corporation stock logo
MSFT
Microsoft
0.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amgen Inc. stock logo
AMGN
Amgen
31,500539.68 million535.10 millionOptionable
Microsoft Corporation stock logo
MSFT
Microsoft
228,0007.43 billion7.43 billionOptionable

Recent News About These Companies

Nvidia Can Outgrow Hyperscaler CapEx: Jensen Huang
4 important takeaways from Nvidia's earnings
The Real Winner of SpaceX's IPO: Mark Zuckerberg
Microsoft's carbon removal plans aren't dead after all
OpenAI Commits $234 Million To Singapore AI Expansion
OpenAI IPO Filing Could Come 'Very Soon:' Report
Nvidia Earnings Face AI Rally Test After 60% Chip Index Surge

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amgen stock logo

Amgen NASDAQ:AMGN

$331.57 +0.82 (+0.25%)
Closing price 05/20/2026 04:00 PM Eastern
Extended Trading
$331.25 -0.32 (-0.10%)
As of 05/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Microsoft stock logo

Microsoft NASDAQ:MSFT

$421.06 +3.64 (+0.87%)
Closing price 05/20/2026 04:00 PM Eastern
Extended Trading
$418.40 -2.66 (-0.63%)
As of 05/20/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.